Settlement with HC Berlin Pharma and Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Shareholder Update
- SUDA Expands Patent Coverage For Sildenafil
- SUDA announces update on ZolpiMist in USA and Canada
- SUDA expands dialogue with World Health Organisation
- HC Berlin Pharma Update
Later from Arovella Therapeutics
- Prospectus for a Renounceable Pro Rata Offer
- Anagrelide Update
- Business Development Update
- SUDA Achieves TGA GMP Licence
- Request for Trading Halt
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics